Yang, Min-Jeong https://orcid.org/0000-0002-0956-7041
Martínez, Úrsula https://orcid.org/0000-0002-4212-5851
Fulton, Hayden J. https://orcid.org/0000-0003-0486-6277
Maconi, Melinda Leigh https://orcid.org/0000-0002-4357-2514
Turner, Kea https://orcid.org/0000-0002-7885-0879
Powell, Sean T.
Chern, Jing-Yi https://orcid.org/0000-0003-0331-9941
Brandon, Thomas H. https://orcid.org/0000-0003-1559-5679
Vidrine, Jennifer I. https://orcid.org/0000-0002-9997-4459
Simmons, Vani N. https://orcid.org/0000-0002-4381-5336
Article History
Received: 6 March 2023
Accepted: 18 July 2023
First Online: 22 July 2023
Declarations
:
: The current study protocol was reviewed by the Moffitt Cancer Center Scientific Review Committee and deemed to be Institutional Review Board exempt and classified as a quality improvement project at the Moffitt Cancer Center.
: All participants consented to participate in this study.
: All participants consented to publish the results.
: Thomas H. Brandon, Ph.D., is on the advisory board for Hava Health, Inc.